Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications.

V Ozenci1, M Kouwenhoven, H Link

  • 1Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden. volkan.ozenci@cck.ki.se

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Nature immunology·2001
Same author

Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.

Scandinavian journal of gastroenterology·2000
Same author

Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.

Clinical immunology (Orlando, Fla.)·2000
Same author

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.

Leukemia·2000
Same author

IL-12 elispot assays to detect and enumerate IL-12 secreting cells.

Cytokine·2000
Same author

Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors?

Cancer genetics and cytogenetics·2000
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Multiple sclerosis (MS) pathogenesis involves immune responses, with cytokines playing a key role. Enzyme-linked immunospot (ELISPOT) assays help clarify conflicting cytokine level findings in MS research.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Medical Research

Background:

  • Multiple sclerosis (MS) is a primary cause of disability in young adults.
  • Despite extensive research, the exact cause of MS remains unknown.
  • Aberrant immune responses, particularly involving cytokines, are implicated in MS pathogenesis.

Purpose of the Study:

  • To explore the role of cytokines in multiple sclerosis pathogenesis.
  • To investigate reasons for conflicting results in previous cytokine studies in MS.
  • To summarize findings from enzyme-linked immunospot (ELISPOT) assays in MS cytokine research.

Main Methods:

  • Review of existing literature on cytokines and MS.
  • Focus on enzyme-linked immunospot (ELISPOT) assay applications.

Related Experiment Videos

  • Analysis of methodological challenges in cytokine quantification.

    • Main Results:

    • Cytokine profiles significantly influence MS disease outcomes.
    • Interferon-gamma (IFN-gamma) has detrimental effects, while Interferon-beta (IFN-beta) shows therapeutic benefits.
    • Conflicting results in cytokine level studies are likely due to methodological issues and cytokine complexity.

    Conclusions:

    • Understanding cytokine involvement is crucial for MS pathogenesis.
    • ELISPOT assays offer a valuable tool for resolving discrepancies in MS cytokine research.
    • Further research is needed to fully elucidate the complex role of cytokines in MS.